Nasdaq · CIK 0001217234
CDNA CareDx, Inc.
A
95 / 100
Material weaknesses
1
Restatements
0
Auditor changes
0
Late filings
0
Quarters with open weakness
1
Remediations
1
Deductions
20
Remediation credit
15
Trailing 24 months from 2024-11-07. Rubric v1. How this is scored.
Disclosures, in the company's words
“we did not fully maintain components of the COSO framework, including elements of the control environment, risk assessment, control activities, and monitoring activities components, that resulted in immaterial corrected errors in the reporting of stock-based compensation expense for the year ended December 31, 2024 and determined that this control deficiency constituted a material weakness in our internal control over financial reporting.”
Remediation disclosed
- 10-Q · filed 2026-10-29 · source filing ↗
“We successfully remediated the material weakness during the year ended December 31, 2025.”
Filings read
- 10-Q · 2026-10-29read
- 10-Q · 2026-07-30queued
- 8-K · 2026-04-28queued
- 10-Q · 2026-04-28queued
- 10-K · 2026-02-25queued
- 10-Q · 2025-11-04queued
- 10-Q · 2025-08-06queued
- 10-Q · 2025-04-30queued
- 10-K · 2025-02-28queued
- 10-Q · 2024-11-04queued
Think something here is wrong? Request a correction. Open corrections hide the affected disclosure until resolved.